Compass Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	218	199	635	311	-	-
Market Cap Growth	-	-68.67%	104.26%	-	-	-
Enterprise Value	66	48	451	170	-38	-11
PE Ratio	-4.68	-4.68	-16.18	-3.78	-	-
PB Ratio	1.46	1.34	3.50	2.22	-	-
P/FCF Ratio	-4.89	-4.89	-18.58	-14.72	-	-
P/OCF Ratio	-4.90	-4.90	-18.60	-15.80	-	-
EV/EBITDA Ratio	-1.19	-1.19	-12.09	-2.11	1.40	0.34
EV/EBIT Ratio	-1.13	-1.13	-11.50	-2.07	1.29	0.32
EV/FCF Ratio	-1.18	-1.18	-13.20	-8.06	1.42	0.33
Debt / Equity Ratio	0.01	0.01	0.02	0.03	0.23	-0.13
Debt / EBITDA Ratio	-0.04	-0.04	-0.08	-0.05	-0.34	-0.47
Debt / FCF Ratio	-0.04	-0.04	-0.09	-0.19	-0.35	-0.46
Quick Ratio	19.54	19.54	11.54	13.59	4.69	2.60
Current Ratio	19.73	19.73	12.05	13.84	4.97	2.67
Interest Coverage	-	-	-	-	-	-27.22
Return on Equity (ROE)	-26.10%	-26.10%	-28.10%	-145.30%	-84.10%	-
Return on Assets (ROA)	-24.50%	-24.50%	-25.50%	-118.40%	-64.50%	-
Return on Capital (ROIC)	-33.51%	-33.51%	-22.57%	-56.82%	-59.80%	32.83%
Earnings Yield	-19.61%	-21.37%	-6.18%	-26.45%	-	-
FCF Yield	-18.76%	-20.44%	-5.38%	-6.80%	-	-
Buyback Yield / Dilution	-20.76%	-20.76%	-67.31%	-104.28%	-359.96%	-
Total Shareholder Return	-20.76%	-20.76%	-67.31%	-104.28%	-359.96%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).